The use of recombinant K39, KMP11, and crude antigen-based indirect ELISA as a serological diagnostic tool and a measure of exposure for cutaneous leishmaniasis in Sri Lanka
- PMID: 38157062
- PMCID: PMC11263736
- DOI: 10.1007/s00436-023-08103-y
The use of recombinant K39, KMP11, and crude antigen-based indirect ELISA as a serological diagnostic tool and a measure of exposure for cutaneous leishmaniasis in Sri Lanka
Abstract
Cutaneous leishmaniasis (CL) in Sri Lanka is caused by Leishmania donovani, a parasite widely known to cause visceral leishmaniasis. Despite the fact that CL is not generally believed to elicit serological immune responses, recent studies show the presence of antibody responses against this atypical form of CL. This study assesses the potential of using recombinant K39 (rK39), KMP11, and crude parasite antigen-based indirect ELISAs as serological diagnostic tools and measures of exposure for CL in Sri Lanka. The study used serum samples from confirmed CL patients (n = 266) and apparently healthy individuals from endemic settings (n = 411). Serum samples from individuals residing in non-endemic areas were used as negative controls. In-house indirect ELISAs were optimized and validated for recombinant antigens. Previously validated crude parasite extract-based indirect ELISA was performed for comparison. The statistical analyses were performed using SPSS v26.0. The rK39 (sensitivity = 71.2%, specificity = 64%) and KMP11 (sensitivity = 79.2%, specificity = 71.4%) based indirect ELISA were shown to be less suitable for the diagnosis of CL, while crude parasite extract-based indirect ELISA (sensitivity = 82.4%, specificity = 85.7%) might be a better method of diagnosis. All 03 ELISAs seemed to be good methods as measures of exposure since correlations were observed between the seropositivity of all 03 ELISAs (rK39: p = 0.037, KMP11: p = 0.007, CrudeAg: p = 0.000) with provincial case incidences. The findings will be important in identifying the disease hotspots in order to design the control measures for CL induced by L. donovani in Sri Lanka.
Keywords: Asymptomatic; Laboratory diagnosis; Leishmania donovani; Sero-prevalence.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Figures





Similar articles
-
First Serological Study Revealing High Humoral Response and Evidence for Antigenic Heterogeneity in Leishmania donovani Induced CL in Sri Lanka.Biomed Res Int. 2020 Sep 29;2020:5271657. doi: 10.1155/2020/5271657. eCollection 2020. Biomed Res Int. 2020. PMID: 33145352 Free PMC article.
-
Clinical and epidemiological studies on the cutaneous leishmaniasis caused by Leishmania (Leishmania) donovani in Sri Lanka.Ann Trop Med Parasitol. 2010 Apr;104(3):213-23. doi: 10.1179/136485910X12647085215615. Ann Trop Med Parasitol. 2010. PMID: 20507695
-
Serological studies on rK39 negative Visceral Leishmaniasis in an endemic focus of Leishmania donovani induced Cutaneous Leishmaniasis.Diagn Microbiol Infect Dis. 2023 Mar;105(3):115873. doi: 10.1016/j.diagmicrobio.2022.115873. Epub 2022 Nov 24. Diagn Microbiol Infect Dis. 2023. PMID: 36543026
-
Diagnosing Cutaneous leishmaniasis using Fluorescence in Situ Hybridization: the Sri Lankan Perspective.Pathog Glob Health. 2019 Jun;113(4):180-190. doi: 10.1080/20477724.2019.1650228. Epub 2019 Aug 20. Pathog Glob Health. 2019. PMID: 31429388 Free PMC article.
-
Is leishmaniasis in Sri Lanka benign and be ignored?J Vector Borne Dis. 2009 Mar;46(1):13-7. J Vector Borne Dis. 2009. PMID: 19326703 Review.
References
-
- Athukorale DN, Seneviratne JKK, Ihalamulla RL, Premaratne UN (1992) Locally acquired cutaneous leishmaniasis in Sri Lanka. J Trop Med Hyg 95(6):432–433 - PubMed
-
- Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S (2005) Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J Immunol 174(11):7160–7171. 10.4049/JIMMUNOL.174.11.7160 - DOI - PubMed
-
- Castellani A (1904) “Leishmania Donovani” in Ceylon. Seventy-Second Annual Meeting of the British Medical Association, BMJ2 629–78. 10.1136/bmj.2.2281.629 - DOI
-
- CDC (2020) Leishmaniasis. https://www.cdc.gov/parasites/leishmaniasis/index.html. Accessed 21 February 2023
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources